William Blair Investment Management LLC Sells 2,543 Shares of Haleon plc (NYSE:HLN)

William Blair Investment Management LLC decreased its holdings in Haleon plc (NYSE:HLN) by 0.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 297,684 shares of the company’s stock after selling 2,543 shares during the period. William Blair Investment Management LLC’s holdings in Haleon were worth $2,459,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of Haleon by 6.0% during the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 93,739 shares of the company’s stock valued at $771,000 after acquiring an additional 5,347 shares in the last quarter. Financial Advocates Investment Management boosted its holdings in shares of Haleon by 18.5% during the 4th quarter. Financial Advocates Investment Management now owns 17,592 shares of the company’s stock valued at $145,000 after acquiring an additional 2,743 shares in the last quarter. Independent Advisor Alliance acquired a new stake in shares of Haleon during the 4th quarter valued at $129,000. Brown Advisory Inc. boosted its holdings in shares of Haleon by 14.1% during the 4th quarter. Brown Advisory Inc. now owns 41,427 shares of the company’s stock valued at $341,000 after acquiring an additional 5,104 shares in the last quarter. Finally, Coldstream Capital Management Inc. boosted its holdings in shares of Haleon by 192.3% during the 4th quarter. Coldstream Capital Management Inc. now owns 36,888 shares of the company’s stock valued at $304,000 after acquiring an additional 24,270 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

HLN has been the topic of several recent research reports. Berenberg Bank initiated coverage on Haleon in a report on Tuesday, August 6th. They set a “buy” rating on the stock. The Goldman Sachs Group downgraded Haleon from a “buy” rating to a “neutral” rating in a report on Tuesday, August 6th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy”.

Haleon Stock Up 1.1 %

Shares of HLN opened at $10.63 on Tuesday. The company has a market capitalization of $48.54 billion, a PE ratio of 35.43, a PEG ratio of 3.10 and a beta of 0.26. Haleon plc has a 12 month low of $7.70 and a 12 month high of $10.65. The stock’s 50-day moving average price is $9.58 and its two-hundred day moving average price is $8.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN) last announced its earnings results on Thursday, August 1st. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.01). The company had revenue of $3.50 billion for the quarter, compared to analyst estimates of $3.55 billion. Haleon had a return on equity of 13.15% and a net margin of 9.71%. During the same period in the previous year, the firm posted $0.08 earnings per share. On average, analysts anticipate that Haleon plc will post 0.46 EPS for the current year.

Haleon Cuts Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 19th. Stockholders of record on Friday, August 16th will be paid a $0.0514 dividend. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, August 16th. Haleon’s dividend payout ratio is 33.33%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.